Table 1.

Characteristics of the 24 patients with focal CHI.

GENDER, n (%)
Female	15 (63%)
Male	9 (37%)
Birth weight (grams), mean (SD), n = 20	3626 (600)
Gestational age (week), median (range), n = 20	40 (33-41)
APGAR-SCORE AT 5 MIN, n (%), n = 12
Score (≥8)	8 (33%)
Score (≤7)	4 (17%)
Age at first symptoms (days), median (range), n = 23	2 (0–30)
Age at first recorded hypoglycaemia (days), median (range), n = 23	2 (0–30)
Maximal glucose infusion rate (mg/kg/min), median (range), n = 21	12.1 (4.4–28.3)
GENETIC MUTATION, n (%)
ABCC8	23 (96%)
KCNJ11	1 (4%)
18F-DOPA-PET/CT LOCALIZATION, n (%)
Head	11 (45.8%)
Body	4 (16.7%)
Tail	5 (20.8%)
Uncinate process	4 (16.7%)
Follow-up time after surgery (months), median (range)	12.5 (0.2–78.9)
Age at last follow-up (years), median (range)	1.7 (0.24–6.97)